3,209 followers
New Research: Exploring the benefits of in-diet versus repeated oral dosing of saracatinib (AZD0530) in chronic studies: insights into pharmacokinetics and animal welfare: Saracatinib/AZD0530 (SAR), a Src tyrosine kinase inhibitor, mitigates… https://t.co/